🔴 HCW Biologics is trading 5% down today with no confirmed company-specific catalyst

HCW Biologics is trading 5.16% lower at $1.20, with no verified company-specific catalyst identified for October 14.

• The biotech sector is also weaker, with XBI down 2.01%; this provides context but does not confirm the reason for the decline.
• The latest company news, on October 9, covered FDA guidance for preparing an IND application. Filing remains targeted for the first half of 2027, and that update does not establish a reason for today’s drop.